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This study developed a hanging-droplet long PCR, a generic and highly sensitive strategy to
facilitate the identification of new human papillomavirus (HPV) genomes. This novel procedure
used for the first time the hanging-droplet PCR technique for the amplification of long DNA
fragments with generic primers targeting the L1 and E1 regions. It was first applied to the
amplification of types belonging to the highly divergent genus Gammapapillovirus (c-PV). The
hanging-droplet long PCR was 100-fold more sensitive than a simple long PCR procedure,
detecting as few as ten copies of HPV-4. Nineteen skin samples, potentially containing putative
HPV types from the c-PV genus, were also screened. The method identified four c-PV genomic
halves from new and previously described putative types, and made the full characterization of
HPV-156 possible. This novel virus meets the criteria for a new species within the c-PV genus,
with nucleotide identities in the L1 ORF ranging from 58.3 to 67.3% compared with
representative types of the current c-PV species. HPV-156 showed the highest identity to HPV-
60 (67.3%) from species c-4, and was consistently closely related to it in both late- and early-
gene-derived phylogenies. In conclusion, this report provides a versatile and highly sensitive
approach that allowed identification of the prototype of a new species within the c-PV genus. Its
application with primers targeting the different genera in which both human and non-human PVs
are distributed may facilitate characterization of the missing members of the family
Papillomaviridae.
INTRODUCTION
Papillomaviruses (PVs) are small, non-enveloped DNA
tumour viruses with a circular genome of nearly 8 kb. PVs
are principally host specific and have been found in .20
different mammalian as well as bird and reptile species (de
Villiers et al., 2004; Herbst et al., 2009). By convention, a
novel PV type shows ,90 % nucleotide identity in the L1
gene with respect to any known PV type, whilst PV types
belonging to new species within a genus share 60–70 %
nucleotide identity with PV types of any other known
species (de Villiers et al., 2004). Definition of a new PV type
requires isolation and characterization of the full-length
genome in order to verify the typical genetic organization of
PVs (de Villiers et al., 2004).
Presently, .150 human PV (HPV) types have been
completely sequenced and have been divided into five
genera (a-, b-, c-, m- and g-PVs) according to the
phylogenetic relationships of their complete L1 gene
sequences (de Villiers et al., 2004). HPVs are further
classified into mucosal/genital and cutaneous types based
on sequence analyses and clinical manifestations (Bernard
et al., 2010). Mucosal/genital HPV types belong to the a-PV
genus and have been divided into low-risk and high-risk
types as inferred from their association with benign and
malignant anogenital lesions, respectively (zur Hausen,
2002). Cutaneous HPV types represent ~75 % of the HPVs
described to date, outnumbering those with mucosal/genital
tropism (Bernard et al., 2010). In addition, skin HPV types
are more genetically divergent and are distributed into the
The GenBank/EMBL/DDBJ accession number for the sequences of
novel HPV type/putative HPV types reported in this paper are
JX429973 (HPV-156), JX429975 (GC23) and JX429974 (GC24).
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five genera in which HPVs are grouped (Bernard et al.,
2010). In contrast to the mucosal/genital HPVs, the
involvement of cutaneous HPV types in human carcinoge-
nesis is still unclear. In fact, cutaneous HPVs have been
found in benign skin warts and in non-melanoma skin
cancer but also on healthy skin (Antonsson et al., 2000).
Although the evolutionary basis for the larger genetic
diversity of the HPV cutaneous types is unknown, it is
speculated that UV light-induced damage may contribute to
a higher mutation rate of the HPVs infecting the sun-
exposed human skin (Forslund, 2007).
Among the cutaneous HPV types, the c-PV genus seems to
be highly divergent, as inferred from generic primer PCR
approaches (Antonsson et al., 2000; Forslund, 2007). More
than 30 c-PV types have been isolated from humans so far
(http://pave.niaid.nih.gov), but it is assumed that a much
greater number exist in nature. In addition, many novel
HPV types/putative types are found segregated outside the
current species (Chouhy et al., 2010; Forslund, 2007),
indicating that additional species within the genus c-PV
need to be defined. Efforts directed towards identifying
novel HPV types are needed in order to have a complete
picture of the c-PV genus to elucidate the evolution and
medical implications of these viruses.
For the past 15 years, several PCR-based methods have
been used for the identification of HPV DNA in skin
lesions (Asgari et al., 2008; Berkhout et al., 2000; Chouhy
et al., 2010; Forslund et al., 2007, 2003; Harwood et al.,
2000, 2004; Shamanin et al., 1994, 1996), as well as in
normal skin (Antonsson et al., 2000; Chen et al., 2008;
Chouhy et al., 2010; Hazard et al., 2007). Overall, 200–250
putative HPV types have been identified in the form of
PCR amplicons of 200–450 bp (Antonsson et al., 2000;
Chouhy et al., 2010; Forslund, 2007, Forslund et al., 1999).
However, ,25 % of these putative HPV types have been
fully cloned and characterized using PCR, rolling-circle
techniques or a combination of both methods (Chen et al.,
2007; de Villiers & Gunst, 2009; Ko¨hler et al., 2011). The
low amplification efficiency of these techniques for long
DNA fragments together with the presence of HPV DNA in
low copy numbers in skin samples (Vasiljevic et al., 2008;
Weissenborn et al., 2005) may have influenced the
identification of the remaining putative HPV types.
Taking this into account, and in order to provide a generic
and highly sensitive method to facilitate the identification
of new HPV genomes, we combined the hanging-droplet
PCR technique with generic primers targeting the L1 and
E1 regions for the amplification of long DNA fragments.
This novel method, which we named ‘hanging-droplet long
PCR’, was applied to the amplification of types belonging
to the highly divergent c-PV genus (Forslund, 2007). This
PCR strategy allowed the identification of four c-PV
genomic halves from new and previously described
putative types, and made possible the full characterization
of HPV-156, a novel virus that meets the criteria for a new
species within the c-PV genus.
RESULTS
Hanging-droplet long PCR method
The hanging-droplet long PCR method was designed to
facilitate the amplification of long DNA fragments with
higher sensitivity than conventional PCR methods used for
the identification of novel PV genomes. To achieve this goal,
a two-step PCR amplification with the single-tube ‘hanging-
droplet’ PCR strategy (Walsh et al., 2001) was applied, using
the same primer pair in both rounds of amplification. A
combination of generic primers located within the L1 and E1
gene regions (primer pairs L1-F/E1-R and E1-F/L1-R, Fig.
1a) was used to generate two overlapping amplicons of
~4000 bp corresponding to HPV genomic halves. It should
be noted that this strategy can be used with different generic
primer pairs. In this work, the widely used FAP primers
(Forslund et al., 2003) were combined with those designed
in the E1 gene region for the amplification of c-PVs. After
the optimization process, the sensitivity of the new method
was compared with an optimized protocol using simple long
PCR. A representative experiment is shown in Fig. 1(b). The
hanging-droplet long PCR detected down to ten copies of
cloned HPV-4, and therefore was 100 times more sensitive
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Fig. 1. The hanging-droplet long PCR strategy. (a) General
strategy for generating HPV DNA genomic halves. The generic
primers used in this work were FAP6085-F (5L1-F), FAP6319-R
(5L1-R), E1Gamma-F (5E1-F) and E1Gamma-R (5E1-R). (b)
Analytical sensitivity comparison of hanging-droplet long PCR and
simple long PCR. PCR products from each PCR strategy were
generated with the E1Gamma-R/FAP6085-F primer pair from a
tenfold dilution series of cloned HPV-4 in a background of 5 ng
human placental DNA (Sigma). RC, Reaction negative control; M,
1 kb ladder (PB-L).
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than the simple long PCR procedure using 40 cycles, which
was able to amplify 1000 plasmid copies. The same
sensitivity was obtained with the simple long PCR procedure
when the number of cycles was 65, the same as used in the
hanging-droplet long PCR (data not shown), confirming the
increase in sensitivity of our novel strategy.
Skin sample screening by hanging-droplet long
PCR and phylogenetic analysis
Next, 19 skin samples potentially containing one or more
putative HPV types from the c-PV genus (Chouhy et al.,
2010) were screened with the hanging-droplet long PCR
using the E1Gamma-F/FAP6319-R and E1Gamma-R/
FAP6085-F primer pairs. Amplicons ranging from 3800
to 4400 bp in size were obtained from five of the 19
samples for the first primer set and four of the 19 samples
for the second primer set (Table 1). Five of these could be
cloned and were identified as HPV genomic halves
corresponding to the previously characterized HPV-23
(b-PV species 2), two putative HPV types described
previously as 230–370 bp PCR fragments (GC01 and
GC10) (Chouhy et al., 2010) and two novel putative
HPV types (GC23 and GC24). Phylogenetic analysis based
on partial L1 sequences of the GC01, GC10, GC23 and
GC24 putative HPV types grouped them into the c-PV
genus (Fig. 2). Pairwise comparisons of types representing
each species allowed us to assign only the GC23 isolate to
species 1 (72.4 % nucleotide identity with HPV-4) (Table
2). In contrast, the GC01 and GC24 isolates (74.6 %
nucleotide identity between them) qualified as members of
a new species according to the current criteria of PV
classification (,71 % nucleotide identity with the HPV
types representing each species), being closely related to
HPV-60 (c-4) (Fig. 2). The same was true for the GC10
isolate (Table 2). In this case, the closest related types to
GC10 were the recently reported HPV-135 and HPV-146
(sequence identities of 67.3 and 63.2 %, respectively)
awaiting species designation (Fig. 2).
Identification of HPV-156, a prototype of a novel
species within the c-PV genus
We started characterizing the full-length genome of the
GC01 isolate from a sun-exposed healthy skin sample (Table
1, patient 89). The amplicon generated with the FAP6085-F/
E1Gamma-R primer pair was unable to be cloned and
identified. In view of this, the GC01 subgenomic sequence
that was amplified with the E1Gamma-F/FAP6319-R primer
pair was used as template to design specific primers to
generate the corresponding overlapping fragment (see
Methods). Using this procedure, the other genomic half of
the novel virus was amplified, cloned and sequenced, and
the complete genome of HPV-156 was obtained.
Table 1. Skin samples screened with the hanging-droplet long PCR
Patient ID Sample type* Putative HPV types
originally detectedD
FAP6085-F/E1Gamma-R primersd E1 Gamma-F/FAP6319-R primersd
00 A GC15 N N
12 A FA27, GC04 N P
17 C FA150 P HPV-23
22 A GC20, FA91 N GC24
42 C FA89, FA66, GC11 N N
42 D FA89, FA66 N N
43 A FA91 N N
44 A FA91, GC12.1 N N
44 C FA91 N N
46 A GC07.2, GC16 N N
54 A FAIMVS9 N N
55 C GC04 N N
59 A GC16 N N
79 A FA8 N N
82 A GC01 N N
89 A GC01, GC12.1, GC13 P GC01
93 B GC19, FA66 P N
95 A GC08 GC23 GC10
98 C FA97 N N
*All samples were collected from superficial cells in the corresponding areas with sterile cotton-tipped swabs pre-wetted in saline solution (0.9 %
NaCl) (Chouhy et al., 2010). A, Healthy skin from a sun-exposed area (forehead); B, healthy skin from a non-sun-exposed area (upper inner arm);
C, perilesion area; D, lesion area.
DScreening was carried out using CUT and FAP primer systems, as described previously (Chouhy et al., 2010).
dN. Negative result; P, unidentified 3800–4400 bp amplicon.
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Sequence analysis of the full-length HPV-156 revealed a
genome of 7329 bp, with a G+C content of 36.2 mol%.
HPV-156 had the principles of genome organization found
in PV (Table 3), potentially encoding five early genes (E6,
E7, E1, E2 and E4) and two late genes (L2 and L1), as well
as a missing E5 ORF, which is a characteristic feature of
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Fig. 2. Phylogeny of the putative HPV types found in this study with respect to reference HPVs. Phylogenetic analysis was done
of partial L1 ORF sequences from the four putative HPV types identified in this study and reference HPVs from b-, c- and m-PV
genera. HPVs from a-PV species 7 were used as the outgroup. Node values represent Bayesian posterior probabilities (BPP).
Shaded in grey are the GC isolates found in this study with the closest related HPV types. c-un, Species not included in the
current HPV taxonomy (Bernard et al., 2010).
Table 2. Pairwise nucleotide identities (%) between putative HPV types and HPV types representing current species within the c-PV
genus (Bernard et al., 2010)
Putative
HPV type
c-PV species
1 2 3 4 5 6 7 8 9 10
HPV-4 HPV-48 HPV-50 HPV-60 HPV-88 HPV-101 HPV-109 HPV-112 HPV-116 HPV-121
GC01 64.6 65.5 64.6 67.1 65.1 63.9 64.1 63.0 65.3 66.7
GC10 65.7 61.1 61.5 63.0 61.2 60.4 67.0 57.5 61.2 61.9
GC23 72.4 65.1 70.0 65.1 64.5 63.6 68.8 62.1 60.2 66.7
GC24 59.5 61.8 63.9 65.3 60.6 57.5 61.5 58.2 61.6 61.9
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human b-PV and c-PV (Ko¨hler et al., 2011). The URR of
HPV-156, containing cis-responsive elements between the
L1 and E6 ORFs, consisted of 544 bp, which falls within the
expected length for the c-PV genus (Ko¨hler et al., 2011).
Within the URR, a TATA box (TATAA) was identified, as
well as four putative binding sites for E2 [ACC(N)6GGT].
Multiple binding sites for transcriptional regulatory factors
such as AP-1, NF-1 and SP-1 were also present within the
URR. The putative proteins of the novel HPV type also
showed typical domains. The E6 gene product of HPV-156
contained the two characteristic zinc-binding domains
CXXC(X)29CXXC separated by 36 aa, and three different
putative PDZ-binding domains [consensus: X(T/S)X(L/V);
HPV-156: PTSL at aa 6–9, KSDL at aa 81–84, and FSLV at
aa 122–125] (Fanning & Anderson, 1999). The putative E7
gene product contained one zinc-binding domain,
CXXC(X)29CXXC, but the LXCXE motif required for
binding to the pRB protein was absent. Analysis of the E1-
coding sequence showed a typical ATP-binding site of
the ATP-dependent helicase [consensus: GXXXXGK(T/S);
HPV-156: GPPDTGKS] (Titolo et al., 1999).
Pairwise comparison of the novel L1 ORF confirmed HPV-
156 as a c-PV, showing nucleotide identities ranging from
58.3 to 67.3 % compared with types representing current c-
PV species (Table 3). Therefore, HPV-156 qualified as a
novel species within the c-PV genus according to the current
criteria for species definition (de Villiers et al., 2004) (Table
3). The same was true when comparing HPV-156 with the
HPV types from the c-PV genus that have been recently
reported and that are awaiting species designation. In fact,
pairwise comparisons of the HPV-156 L1 ORF showed
nucleotide identities ranging from 60.4 to 64.4 % compared
with HPV-126 (61.9 %), HPV-135 (63.6 %), HPV-136
(64.4 %), HPV-137 (60.4 %), HPV-140 (61.8 %), HPV-141
(63.0 %), HPV-144 (64.4 %) and HPV-155 (61.8 %).
HPV-156 showed the highest L1 identity to HPV-60
(67.3 %), member of species c-4 (Table 3). Although the
novel virus was consistently closely related to HPV-60 in
both late- and early-gene-derived phylogenies inside the c-
PV genus (Fig. 3), some contradictory relationships were
found. In the late-gene analysis (Fig. 3, left), HPV-60 (c-4)
and HPV-156 were the closest relatives of HPV-144
(BPP50.99). However, in the early-gene analysis, both
types were closely related to the unclassified c-PV types
HPV-146, HPV-135, HPV-128 and HPV-153 (BPP50.83),
whilst HPV-144 showed a highly supported relationship
(BPP50.99) with members of c-1 (Fig. 3, right).
DISCUSSION
In the present study, we designed an approach to facilitate
the identification of novel HPV genomes with higher
sensitivity than conventional PCR methods used for long
DNA fragment amplifications. The hanging-droplet long
PCR is based on the use of two generic primer pairs
targeting the L1 and E1 gene regions, and the highly
sensitive hanging-droplet PCR technique (Walsh et al.,
2001) as the amplification strategy.
Table 3. Sizes of putative proteins encoded by the putative ORFs of HPV-156, their nucleotide positions and nucleotide identities
with types representing c-PV species
URR, Upstream regulatory region.
HPV-156 (7329 nt) Putative ORF
E6 E7 E1 E2 E4 L2 L1 URR
Protein size (aa) 140 97 608 399 201 551 509 –
Nucleotide sequence
(pre-stop codon)
(nt)
106–525 525–815 805–2628 2567–3763 2925–3527 3775–5427 5361–6887 544
HPV type (species) Nucleotide identity (%)
E6 E7 E1 E2 E4 L2 L1 URR
HPV-4 (c-1) 58.6 54.9 64.0 54.0 51.7 52.6 61.9 40.4
HPV-48 (c-2) 57.9 57.4 60.5 56.5 48.4 49.0 62.3 43.0
HPV-50 (c-3) 54.1 50.0 61.0 55.8 47.2 49.0 62.4 38.1
HPV-60 (c-4) 59.0 65.3 65.8 60.6 56.6 56.1 67.3 59.2
HPV-88 (c-5) 54.8 61.2 63.3 55.3 36.0 51.4 64.1 45.0
HPV-101 (c-6) – 52.6 57.0 53.7 42.9 47.2 58.3 33.5
HPV-109 (c-7) 50.1 50.9 60.8 55.3 39.6 49.2 60.7 37.2
HPV-112 (c-8) 57.9 59.5 61.5 56.9 45.8 50.3 63.2 46.5
HPV116 (c-9) 57.2 56.4 63.8 55.9 47.4 48.4 60.5 44.4
HPV-121 (c-10) 54.4 57.1 62.3 56.6 45.4 52.3 61.9 43.8
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The method was first applied for the amplification of
several putative HPV types belonging to the c-PV genus,
using the newly designed c-PV generic primers from the E1
region and the widely used FAP primers (Forslund et al.,
2003). This approach was 100 times more sensitive than a
single-round long PCR procedure in the amplification of
an HPV-4 genomic half (Fig. 1b). The increase in
sensitivity was due to the application of the hanging-
droplet PCR technique, used for the first time in this work
for the amplification of long DNA fragments. This is clearly
an advantage over rolling-circle amplification, which
requires the presence of high HPV copy numbers in the
sample to succeed in the identification of full-length HPV
genomes (Ko¨hler et al., 2010; Ko¨hler et al., 2011). The
combination of rolling-circle amplification with long PCR
has improved the detection of some virus types (de Villiers
and Gunst, 2009; Ko¨hler et al., 2011). However, this still
depends on the use of two different methodologies that
require individual optimization, and the sensitivity of the
whole procedure has not been assessed. As cutaneous HPV
types are commonly present at very low copy numbers in
both healthy skin and lesions (Vasiljevic et al., 2008;
Weissenborn et al., 2005), our strategy is a useful tool to
identify novel viruses in these samples.
The hanging-droplet long PCR offered the possibility to
screen different viruses in clinical samples with a single
methodology, without the need for multiple primer sets to
obtain long HPV DNA fragments (Table 1). This is an
important advantage over existing methods, as clinical
samples are often the only reservoir of the novel viruses
under study. Although the generic primer pairs used in this
study were not able to amplify the corresponding genomic
halves of a given HPV type in a sample (Table 1), we do not
exclude the possibility of success with other samples (Fig.
1). It is well known that PCR amplification efficiency
depends on the size of the PCR fragment intended to be
amplified, the initial amount of target DNA and the
number of mismatches between target DNA and primers.
The latter seemed to be the cause of the lack of
amplification of both genomic halves of the putative
HPV types identified in this report. In fact, the GC23
genomic half amplified using the FAP6085-F/E1Gamma-R
primer pair presented seven mismatches with the
E1Gamma-F/FAP6319-R primer pair (data not shown).
The same was true for the 4 kb fragments of putative types
GC01, GC10 and GC24, successfully amplified with the
E1Gamma-F/FAP6319-R primer pair, but presenting one,
four and one mismatches, respectively, with the FAP6085-
F/E1Gamma-R primer pair (data not shown). It is worth
noting that all primers used for screening were generic;
therefore, they could have different efficiencies for each
particular type attempting to be amplified. Finally, our
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Fig. 3. Early- and late-gene phylogeny of HPV-156, a prototype of a novel species within the c-PV genus. Phylogenetic trees
are shown of HPV-156 and 40 representative types of genus c-PV based on full-length L1 ORF sequences (left) for late-gene
analysis and concatenated E1–E2 ORF sequences (right) for early-gene analysis. In both trees, an a-PV (HPV-18) was used as
the outgroup. The numbers on nodes indicate BPP. The closest relative species to HPV-156 are shaded in grey in each tree.
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strategy may be used with primers designed for the
amplification of 7–8 kb as reported by others (de Villiers
& Gunst, 2009; Ko¨hler et al., 2011; Vasiljevic et al., 2008)
but with improved sensitivity.
Using the hanging-droplet long PCR, we obtained 4 kb
fragments corresponding to genomic halves of four
putative HPV types (Table 1). GC01 and GC10 were
identified previously as PCR amplicons with the FAP and
CUT primers, respectively (Chouhy et al., 2010). However,
GC23 and GC24 were novel putative HPV types identified
for the first time in this work (Table 1). Moreover, four
amplicons of the expected size (termed ‘P’, Table 1), which
must be identified and characterized, were obtained.
Curiously, a 4 kb fragment corresponding to HPV-23 (b-
PV species 2) was identified with the E1Gamma-F/
FAP6319-R primer pair (Table 1). It is worth noting that
the generic primers from the E1 gene region were designed
for the amplification of HPVs belonging to the c-PV genus.
However, the presence of only two mismatches between the
E1Gamma-F primer sequence and the corresponding
targeting sequence in HPV-23 suggests that, under certain
conditions, HPV types belonging to genera other than c-
PV may be amplified with this strategy.
Phylogenetic analysis based on partial L1 sequences of the
putative HPV types grouped them into the c-PV genus
(Fig. 2 and Table 2). The novel GC23 putative HPV type
could be assigned to species c-1, whilst GC24 was
segregated outside the defined species and was closely
related to the GC01 isolate (Fig. 2). Since the GC01 and
GC10 isolates were first identified (Chouhy et al., 2010), six
new species (c-6 to c-10) have been defined within the c-
PV genus (Bernard et al., 2010). However, these isolates
cannot be assigned to the current species (Fig. 2), which
suggests the need to progress in the identification of the
missing taxa in order to have a complete picture of the
diversity of this genus.
Most of the HPV types/putative types identified with the
hanging-droplet long PCR strategy differed from those that
were detected originally with the FAP and/or CUT primer
systems (Table 1) (Chouhy et al., 2010). These differences
may be due to the particular specificity of each primer pair
with respect to the different HPV types/putative types, as
the sensitivities of the CUT and FAP amplification
methodologies (Chouhy et al., 2010; Forslund et al.,
2003) were similar to those obtained with the hanging-
droplet long PCR system. All this clearly indicates that the
identification of new HPV types depends not only on
the use of a highly sensitive technique but also on the
combination of different generic primer pairs. Thus,
the strategy presented here is versatile and might be
applied with different generic primer pairs, targeting the c-
PV and other PV genera, to facilitate and speed up
characterization of the missing members of the family
Papillomaviridae. Taking this into account, we started the
characterization of one of the putative HPV types, isolate
GC01. This novel viral type, designated HPV-156,
presented a genome organization and putative proteins
that resembled those of other c-PV (Ko¨hler et al., 2011).
The putative E7 and E6 proteins contained one and two
zinc-binding domains, respectively, but E7 did not have the
pRB-binding motif. Interestingly, three different putative
PDZ-binding domains were found within the E6 protein
sequence. A specific characteristic of oncogenic mucosal
HPV types is a PDZ-binding motif on the carboxyl
terminus of E6, which is important in cell proliferation,
cell polarity and cell transformation (Cavatorta et al.,
2004). However, PDZ-binding domains were not found at
the carboxyl terminus of the HPV-156 E6 protein. PDZ
domains located outside the carboxyl-terminal region have
also been found in other HPV types belonging to the c-PV
genus such as HPV-130, HPV-131, HPV-132, HPV-133,
HPV-134 and HPV-149 (Ko¨hler et al., 2011).
HPV-156 was first identified as the GC01 putative HPV
type with FAP primers in a sun-exposed healthy skin
sample derived from an 83-year-old male (Table 1, patient
82) with basal cell carcinoma in the upper lip (Chouhy
et al., 2010). In the present study, its full-length genome
was also characterized from a healthy skin sample (Table 1,
patient 89), suggesting HPV-156 as a commensal agent.
Further detection of HPV-156 in lesions and healthy skin
in individuals from other geographical areas may clarify the
medical significance of this virus and its global prevalence.
Phylogenetic analyses of the complete L1 ORF of the novel
virus and types representing current species indicated
HPV-156 as the prototype of a new species within the c-PV
genus (Fig. 3, left, and Table 3). HPV-156 also meets the
criteria for a new species with respect to the recently
reported c-PV types with unclassified species (HPV-126,
HPV-135, HPV-136, HPV-137, HPV-140, HPV-141, HPV-
144 and HPV-155; http://pave.niaid.nih.gov).
We investigated early and late genes in separate phyloge-
netic analyses to explore possible incongruent tree topolo-
gies. Although HPV-156 and HPV-60 (c-4) were found to be
the closest relatives in both phylogenies without incon-
gruence between them (Fig. 3), the internal topologies
showed contradictory relationships. Incongruent tree topol-
ogies between early- and late-gene phylogenies have been
explained by recombination events (Gottschling et al.,
2007), which have been detected in a-PV (Narechania
et al., 2005), c-PV (Ko¨hler et al., 2011), o-PV and u-PV
(Rector et al., 2008; Robles-Sikisaka et al., 2012) genera.
However, general conclusions about PV evolution may be
premature and largely speculative as long as the knowledge
about PV diversity is limited (Bravo et al., 2010). Increasing
the taxon sampling by isolating and sequencing novel PVs
may shed light on virus evolution and on the interactions
with their hosts. One of the cornerstones for the identifica-
tion of new full-length PV types is the possibility of
amplifying them with high sensitivity. In this regard, our
report provides a versatile and highly sensitive approach that
allowed the identification not only of a new HPV but also of
a new species within the c-PV genus. The application of the
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hanging-droplet long PCR system with primers targeting the
different genera in which both human and non-human PVs
are distributed will help us to gain a complete picture of the
family Papillomaviridae to elucidate the diversity, evolution
and medical implications of these viruses.
METHODS
Skin samples. Nineteen skin samples from 17 immunocompetent
patients were used for this study. All samples were collected in a
previous study to determine the HPV prevalence and type spectrum
in skin diseases and in healthy skin areas in a group of patients from
Argentina (Chouhy et al., 2010). All samples selected contained one
or more putative HPV types from the c-PV genus according to the
CUT and/or FAP primer systems screening (Chouhy et al., 2010).
c-PV generic primer design in the E1 gene region. DNA
sequences from the E1 ORF of eight characterized HPVs belonging
to six known species within the c-PV genus [HPV-4 and HPV-65 (c-1),
HPV-48 (c-2), HPV-50 (c-3), HPV-60 (c-4), HPV-88 (c-5), HPV-101
and HPV-103 (c-6)] were aligned using MEGA4 (Tamura et al., 2007).
Primer candidates obtained with the Prima-Clade program (http://
www.umsl.edu/services/kellogg) were compared to find those presenting
fewer mismatches, and analysed for primer–dimer and primer-hairpin
formations. After this analysis, E1Gamma-F (59-KGGHCCWCC-
AGATACWGG-39) and E1Gamma-R (59-TCTTGIWGTGCAWCGR-
AACG-39) primers were selected, corresponding to positions 2093–2110
and 2572–2591, respectively, in the HPV-4 genome.
‘Hanging-droplet’ long PCR. The general strategy for generating
HPV DNA genomic halves is depicted in Fig. 1(a). E1 c-PV primers
were combined with the previously described FAP primers (Forslund
et al., 2003) to generate overlapping amplicons with expected lengths
of 3723 bp (E1Gamma-F/FAP6319-R primer pair) and 4362 bp
(E1Gamma-R/FAP6085-F primer pair) in the HPV-4 genome
(GenBank accession no. NC_001457). Amplifications were performed
using the single-tube hanging-droplet PCR technique (Walsh et al.,
2001), with the conditions described below. A thermal cycler
(Mastercycler Personal; Eppendorf) was used in all experiments
involving PCR.
The primary 20 ml reaction mixture was placed in a reaction tube and
covered with one drop of mineral oil. After the addition of the sample
(5 ml), the mixture had a final volume of 25 ml containing 0.5 mM of
each combination of the generic primers (E1Gamma-F/FAP6319-R or
FAP6085-F/ E1Gamma-R), 500 mM of each dNTP, 16 PCR buffer
and 2 U enzyme mix (Expand Long Range dNTPack; Roche). Before
the tube was closed, a 25 ml droplet, containing the same reaction
mixture (but with 1.8 mM of each combination of E1Gamma-F/
FAP6319-R or FAP6085-F/E1Gamma-R generic primers, 600 mM of
each dNTP and 4 U of enzyme mix), was placed in the centre of the
inside of the reaction tube cap. Using the thermal cycler programmed
for block temperature without heated lid, the mixture was heated for
2 min at 92 uC, followed by 25 cycles of 15 s at 92 uC, 48 uC
(E1Gamma-F/FAP6319-R) or 50 uC (FAP6085-F/E1Gamma-R) for
40 s and 4 min at 68 uC. After the first round of amplification, the
‘hanging droplet’ was incorporated into the reaction mixture (final
volume 50 ml) by spinning down at 11 000 g for 1 min, and a second
round of 40 cycles was performed [15 s at 92 uC, 48 uC (E1Gamma-F/
FAP6319-R) or 50 uC (FAP6085-F/E1Gamma-R) for 40 s and 4 min
at 68 uC (in the last 30 cycles the elongation time was increased by
15 s each cycle)]. HPV amplicons were identified by size determina-
tion under UV light after electrophoresis in a 1 % agarose gel and
ethidium bromide staining.
All hanging-droplet long PCR optimizations were carried out with a
plasmid containing the complete genome of HPV-4 as template,
available in our laboratory. The sensitivity of the new method was
compared with an optimized protocol using simple long PCR with
the E1Gamma-R/FAP6085-F primer pair. The reaction mixture (final
volume 50 ml) and the amplification protocol was the same as that
used in the amplification of the second round of the hanging-droplet
long PCR.
Cloning, DNA sequencing and phylogenetic analysis. Bands of
~4 kb were excised from the gel and purified using a NucleoSpin
Extract II kit (Macherey-Nagel). All the amplicons were cloned using
a pGEM-T Easy Cloning kit (Promega). DNA sequencing was
performed using sequencing facilities at the University of Maine DNA
Sequencing Facility (ME, USA).
Sequences were compared with available HPV sequences in GenBank
(http://www.ncbi.nlm.nih.gov/) using the BLAST server. Protein
sequence-derived nucleotide multiple alignments and pairwise
alignments were performed with MEGA5 (Tamura et al., 2011), and
phylogenetic relationships were inferred by Bayesian analysis using
BEAST version 1.6.2 (Drummond & Rambaut, 2007). To do this,
Markov chain Monte Carlo simulations were performed during 107
generations, sampling one state every 1000 generations, with a burn-
in of 10 %. The evolutionary substitution model for each run was set
as rtREV+c.
For the phylogenetic analysis of novel (GC23 and GC24) and
previously identified (GC01 and GC10) putative HPV types, the
corresponding FAP amplicon and L1 sequences from representative
HPV types were used. New putative HPV types and novel putative
species within a genus were defined according to the current criteria
based on the nucleotide identities in the L1 fragment sequences (de
Villiers et al., 2004).
For the phylogenetic analysis of HPV-156, sequences from repres-
entative HPV types of the c-PV genus were used. In order to explore
possible incongruent tree topologies of HPV-156, we investigated
early and late genes in separate phylogenetic analyses. For late-gene
analysis, the L1 ORF was used. For early-gene analyses, the E1–E2
ORFs were used, but the hinge region of E2, including the highly
divergent E4 gene, was eliminated from all phylogenetic analyses. All
sequences from the previously characterized HPV types were obtained
from the PV genome database (http://pave.niaid.nih.gov).
Identification of the full-length genome of HPV-156. HPV-156
was isolated from a swab sample collected from a sun-exposed healthy
skin area derived from a 60-year-old female with a seborrheic keratosis
lesion on the face. HPV-156 corresponded to the previously reported
putative type GC01 (Chouhy et al., 2010). The complete genome
sequence of the novel HPV-156 type was obtained by generating
overlapping amplicons. One of these was obtained with the E1Gamma-
F/FAP6319-R primer pair and the hanging-droplet long PCR method
described above. The other overlapping amplicon was obtained with
the specific primers GC01-F (59-CCTTATGGATGCAGACCACTGG-
39) and GC01-R (59-AACTCCAGCAAGCAAAGGTAGCA-39), both
designed using the 39 and 59 regions of the GC01 genomic half obtained
with the E1Gamma-F/FAP6319-R primer pair as sequence template
and the FastPCR program (Kalendar et al., 2009). Reaction mixtures
and cycling conditions were the same as those used in the hanging-
droplet long PCR, except in the reaction mix of the second round of
amplification in which 1.2 mM each specific primer was used. The
annealing temperatures of the GC01-F/GC01-R primer pair were 52
and 50 uC in the first and second rounds of amplification, respectively.
Amplicons of ~4 kb were purified, cloned and sequenced as described
above. Each GC01 genomic half was fully sequenced by primer walking
on both DNA strands for complete identification. DNA clones and the
corresponding sequences were submitted to the International
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Reference Centre for Papillomaviruses at the German Cancer Research
Centre (Heidelberg, Germany) for official designation as HPV-156, and
the sequences were reconfirmed.
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